Results 261 to 270 of about 6,547,471 (339)
Preoperative Imaging Assessment of Lymphovascular Invasion in Breast Cancer: Current Evidence, Technical Advances, and Future Directions. [PDF]
Wang H, Huang C, Wang Y, Liu Y.
europepmc +1 more source
Most autophagic cell death studies lack evidence of causality
Of 104 studies claiming autophagic cell death (ACD), only 13 demonstrated both causality and exclusion of apoptosis to confirm true ACD. Most studies relied on correlation‐level data or measured autophagy in isolation, revealing pervasive methodological shortcomings.
Ali Burak Özkaya, Yasmin Ghaseminejad
wiley +1 more source
The interplay between the VEGF-C/VEGFR-3 axis and CCL21/CCR7 axis in tumor cell invasion [PDF]
Amine Issa
openalex +1 more source
A Multidisciplinary Perspective on Breast Phyllodes Tumors: A Literature Review. [PDF]
Naum AG +5 more
europepmc +1 more source
Statins, identified via the Comparative Toxicogenomics Database, promote monocytic differentiation and apoptosis in non‐APL AML cells by upregulating DPYSL2A through a KLF4‐dependent pathway. Mevalonate supplementation reversed these effects, indicating involvement of the mevalonate pathway.
Mina Noura +7 more
wiley +1 more source
From cold to hot tumors: feasibility of applying therapeutic insights to TNBC. [PDF]
Yan S, Sun X, Wang K.
europepmc +1 more source
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
E. Raymond +19 more
semanticscholar +1 more source
Key role for inhibins in effective T cell activation, migration and Th17 differentiation
Activins/inhibins modulate immune responses. Here, we show that inhibins can be produced very early after T cell activation and can act in an autocrine way, favoring Th1 versus Th17 differentiation and CCL19/CCL21 mediated migration. Recombinant inhibin A can restore the Th1/Th17 balance, highlighting the role of inhibins as key regulators of T cell ...
Sandra Ortega‐Francisco +5 more
wiley +1 more source
Transcriptomic analysis identifies a potential target for bevacizumab resistant glioblastoma. [PDF]
Lodha R +16 more
europepmc +1 more source

